
Biotech ETFs XBI and PBE diverge sharply in structure and returns, impacting investor choice.
The SPDR S&P Biotech ETF (XBI) and Invesco Biotechnology & Genome ETF (PBE) differ significantly in portfolio structure and performance. XBI uses a modified equal-weight approach across 100+ biotech stocks, favoring small- and mid-cap clinical-stage ...
